Mitsubishi UFJ Asset Management Co. Ltd. reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 41.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 123,767 shares of the company's stock after selling 88,280 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.10% of Henry Schein worth $8,477,000 as of its most recent SEC filing.
Several other hedge funds also recently added to or reduced their stakes in the stock. CenterBook Partners LP purchased a new position in shares of Henry Schein during the first quarter worth approximately $433,000. Ontario Teachers Pension Plan Board grew its position in shares of Henry Schein by 797.9% during the first quarter. Ontario Teachers Pension Plan Board now owns 37,543 shares of the company's stock worth $2,571,000 after acquiring an additional 33,362 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of Henry Schein by 1.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,203,676 shares of the company's stock worth $82,440,000 after acquiring an additional 11,999 shares during the last quarter. ASR Vermogensbeheer N.V. purchased a new position in shares of Henry Schein during the first quarter worth approximately $318,000. Finally, Cary Street Partners Financial LLC acquired a new stake in shares of Henry Schein during the first quarter worth $553,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
HSIC has been the subject of several recent research reports. Barrington Research decreased their price target on Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a report on Wednesday, August 6th. Robert W. Baird reaffirmed a "neutral" rating and set a $72.00 price target (down from $82.00) on shares of Henry Schein in a report on Monday, July 14th. JPMorgan Chase & Co. reduced their target price on Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a report on Thursday, August 7th. Wells Fargo & Company reduced their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Finally, Evercore ISI reduced their target price on Henry Schein from $78.00 to $70.00 and set an "in-line" rating for the company in a report on Wednesday, August 6th. Nine analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $75.58.
Read Our Latest Stock Report on HSIC
Henry Schein Trading Down 0.0%
Shares of NASDAQ:HSIC traded down $0.01 during trading on Friday, reaching $67.91. 898,017 shares of the stock were exchanged, compared to its average volume of 1,771,506. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The firm has a market cap of $8.23 billion, a price-to-earnings ratio of 21.92, a price-to-earnings-growth ratio of 2.28 and a beta of 0.81. The firm's 50-day moving average price is $70.86 and its 200 day moving average price is $70.90.
Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The company had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. The firm's revenue was up 3.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.23 EPS. On average, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.
Henry Schein Profile
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.